Form 8-K - Current report:
SEC Accession No. 0001789769-22-000063
Filing Date
2022-06-13
Accepted
2022-06-13 17:08:59
Documents
12
Period of Report
2022-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K til-20220613.htm   iXBRL 8-K 46595
  Complete submission text file 0001789769-22-000063.txt   189299

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20220613.xsd EX-101.SCH 1890
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20220613_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20220613_pre.xml EX-101.PRE 13036
6 EXTRACTED XBRL INSTANCE DOCUMENT til-20220613_htm.xml XML 12177
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 221012494
SIC: 2836 Biological Products, (No Diagnostic Substances)